| Philip W Kocoloski, DO | |
|
2945 Maple Ave, Zanesville, OH 43701-1762 | |
| (740) 454-4712 | |
| Not Available |
| Full Name | Philip W Kocoloski |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2945 Maple Ave, Zanesville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033104104 | NPI | - | NPPES |
| 0841665 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 34005265 (Ohio) | Primary |
| 208VP0000X | Pain Medicine - Pain Medicine | 34-005265 (Ohio) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Philip W Kocoloski, DO 945 Bethesda Dr Ste 200, Zanesville, OH 43701-1880 Ph: (740) 454-4788 | Philip W Kocoloski, DO 2945 Maple Ave, Zanesville, OH 43701-1762 Ph: (740) 454-4712 |
News Archive
The American Society for Radiation Oncology is continuing its commitment to Target Safely, a six-point patient protection plan developed in January 2010, to improve the safety and quality of radiation therapy treatments and reduce the chances of medical errors.
Medica's clinic-based chronic care management program with six clinic partners shows that focusing on care coordination is beginning to deliver promising results. A recent program evaluation reported that members participating in the clinical pilots had 1 percent more doctor visits and 3 percent more prescription fills than members with similar conditions seen in traditional clinic settings.
Biocept, Inc., a molecular diagnostics company commercializing and developing biomarkers to improve the detection and treatment of cancer, announces the launch of the CLIA-validated androgen receptor expression assay using a patient's blood for the detection and monitoring of late-stage prostate cancer and a certain form of breast cancer.
CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to conduct its proposed clinical trial using CytoSorb® intra-operatively in patients undergoing complex cardiac surgery requiring the use of a heart-lung machine.
RaySearch Laboratories AB announces that the first patient in Europe has been treated with a treatment plan created with RaySearch's treatment planning system RayStation.
› Verified 2 days ago
Jim Sponaugle, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 800 Forest Ave, Zanesville, OH 43701 Phone: 513-672-3309 Fax: 513-672-3323 | |
Dale Edwards, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2951 Maple Ave, Zanesville, OH 43701 Phone: 513-672-3309 Fax: 513-672-3323 | |
Dr. David J Rogoski, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3540 Riverside Airport Rd, Zanesville, OH 43701 Phone: 740-453-5881 | |
Dr. Howard Henry Robinson Jr., MD, MBA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2951 Maple Ave, Zanesville, OH 43701 Phone: 740-837-4075 | |
Craig Deleon, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 2951 Maple Ave, Zanesville, OH 43701 Phone: 513-672-3309 Fax: 513-672-3323 | |
Myron Powelson Iii, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2951 Maple Avenue, Zanesville, OH 43701 Phone: 513-672-3309 Fax: 513-672-3323 |